31 Anti-takeover provisions in the Company's charter and bylaws may prevent or frustrate attempts by stockholders to change the board of directors or current management and could make a third-party acquisition of the Company dif icult. The SEC has adopted regulations, which generally define "penny stock" to be an equity security that has a market price of less than $5.00 per share, subject to specific exemptions. The market price of our common stock is less than $5.00 per share and therefore would be a "pen ...

Technologically, we are increasingly leaning into AI with its data and predictive capabilities to create better and faster analytics and data delivery, targeting more pervasive forms of patient monitoring and lifestyle management. We are also actively evaluating and, in some cases, negotiating with other medical device distributors that have geographic or vertical coverage that complements our existing distribution networks to further expand our distribution strategy. Our Biosphere products and services are ...

Preferred Stock Dividends The Series A Preferred Stock is convertible into shares of common stock commencing 24 months after the issuance date of the Series A Preferred Stock. Upon which, on a monthly basis, up to 5% of the aggregate amount of the Purchase Price can be converted (subject to adjustment for changes in the Holder's ownership of the underlying Series A Preferred Stock). The conversion price is equal to the greater of $.001 or a 15% discount to the volume-weighted average price ("VWAP") of the C ...

Biotricity, Inc. (NASDAQ:BTCY) Q2 2023 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Waqaas Al-Siddiq - Chairman, Chief Executive Officer & Founder John Ayanoglou - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Michael Donovan - H.C. Wainwright Operator Good day, and welcome to the Biotricity's Fiscal Second Quarter 2023 Financial Results Conference Call. Today's c ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share BTCY The NASDAQ Stock Market LLC Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from ______________ ...

Biotricity, Inc. (OTC:BTCY) Q1 2023 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Waqaas Siddiq - Chairman, Chief Executive Officer and Founder John Ayanoglou - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital markets Kevin Dede - HC Wainwright Operator Good day and welcome to the Biotricity's Fiscal First Quarter 2023 Financial Results Conference Call. Today's conference is b ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share BTCY The NASDAQ Stock Market LLC Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from ______________ to__ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-56074 BIOTRICITY INC. (Exact name of registrant as specified in its charter) NEVADA 30-0983531 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identif ...

Biotricity, Inc. (OTC:BTCY) Q3 2022 Earnings Conference Call February 15, 2022 4:15 PM ET Company Participants Waqaas Al-Siddiq – Chairman, Chief Executive Officer and Founder John Ayanoglou – Chief Financial Officer Conference Call Participants Allen Klee – Maxim Group Tim Moore – Zacks Small Cap Research Chet White – Helios Alpha Operator Good day, and welcome to Biotricity's Fiscal 2022 Third Quarter Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to tu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share BTCY The NASDAQ Stock Market LLC Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the period from ______________ ...